Lilly Sees Success With Antibody Treatment Combination
Indianapolis-based Eli Lilly and Co. has released the results of another Phase 3 trial of its COVID-19 antibody therapies. The company says the combination of its therapies bamlanivimab and etesvimab... Read More
